RARX - Ra Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RARX (1481512)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
 F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
26 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m
2020-03-17
 RARXRicardo AlonsoSee RemarksS - Sale$44.25-2,2880-100%-$101,244
D
2020-03-16
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$45.16-10,5957,132-60%-$478,521
D
2020-02-18
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$46.61-10,5957,132-60%-$493,850
2020-01-17
 RARXRicardo AlonsoSee RemarksS - Sale$47.02-2,2852,288-50%-$107,441
D
2020-01-15
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$46.95-10,5957,132-60%-$497,441
2019-12-17
 RARXRicardo AlonsoSee RemarksS - Sale$47.08-2,2854,573-33%-$107,568
D
2019-12-17
 RARXRead SimonChief Scientific OfficerS - Sale+OE$47.08-10,0006,234-62%-$470,821
D
2019-12-16
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$47.23-10,5957,132-60%-$500,351
D
2019-11-15
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$46.66-10,5957,132-60%-$494,319
D
2019-11-14
 RARXRead SimonChief Scientific OfficerS - Sale+OE$46.68-10,0006,234-62%-$466,808
2019-10-17
 RARXRicardo AlonsoSee RemarksS - Sale$46.70-2,2856,858-25%-$106,710
D
2019-10-16
 RARXRead SimonChief Scientific OfficerS - Sale+OE$46.87-10,0006,234-62%-$468,726
D
2019-10-15
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$46.89-10,5957,132-60%-$496,769
D
2019-09-16
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$25.26-10,5957,132-60%-$267,675
D
2019-09-12
 RARXRead SimonChief Scientific OfficerS - Sale+OE$25.41-10,0006,234-62%-$254,050
D
2019-08-23
 RARXRead SimonChief Scientific OfficerS - Sale+OE$27.77-10,0006,234-62%-$277,703
D
2019-08-23
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$27.77-10,5957,132-60%-$294,226
2019-08-23
 RARXRicardo AlonsoSee RemarksS - Sale$27.89-2,2859,143-20%-$63,740
D
2019-07-17
 RARXRead SimonChief Scientific OfficerS - Sale+OE$32.95-10,0006,234-62%-$329,479
D
2019-07-15
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$33.10-10,5957,132-60%-$350,647
2019-06-21
 RARXRicardo AlonsoSee RemarksS - Sale$23.72-2,85711,428-20%-$67,782
D
2019-06-18
 RARXRead SimonChief Scientific OfficerS - Sale+OE$22.25-10,0006,234-62%-$222,467
D
2019-06-17
 RARXFarzaneh-Far RaminChief Medical OfficerS - Sale+OE$21.84-10,5957,132-60%-$231,384
2018-12-14
 RARXNew Enterprise Associates 13 LP10%P - Purchase$15.50+645,1616,135,234+12%+$9,999,996
2018-12-12
 RARXRa Capital Management, LLCDir, 10%P - Purchase$15.50+1,006,4524,858,260+26%+$15,600,006
2018-12-14
 RARXShah Rajeev M.Dir, 10%P - Purchase$15.50+1,006,4524,858,260+26%+$15,600,006
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top